Gene Therapy
Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.
131 stocks
| # | Name | Holding | Trade Value |
Theme Stocks |
% of Portfolio | Status | |
|---|---|---|---|---|---|---|---|
| 26 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
| $314M | +$8.51M | 2 | 0.55% | Increased |
|
| 27 |
JP Morgan Chase
New York
| $312M | +$5.5M | 20 | 0.08% | Increased |
|
| 28 |
Manning & Napier Advisors
Fairport,
New York
| $302M | +$64.5M | 1 | 1.76% | Increased |
|
| 29 |
Bank of New York Mellon
New York
| $296M | +$1.25M | 32 | 0.09% | Increased |
|
| 30 |
Goldman Sachs
New York
| $286M | +$33.7M | 25 | 0.09% | Increased |
|
| 31 |
Capital World Investors
Los Angeles,
California
| $277M | +$87M | 4 | 0.08% | Increased |
|
| 32 |
Jennison Associates
New York
| $276M | +$23.2M | 9 | 0.27% | Increased |
|
| 33 |
BBA
Baker Bros. Advisors
New York
| $272M | +$14.4M | 10 | 2.25% | Increased |
|
| 34 |
Millennium Management
New York
| $261M | +$34.7M | 24 | 0.55% | Increased |
|
| 35 |
JCG
JHL Capital Group
Chicago,
Illinois
| $256M | $0 | 1 | 22.47% | Maintained |
|
| 36 |
OrbiMed
New York
| $256M | -$25.9M | 7 | 2.32% | Reduced |
|
| 37 |
Ameriprise
Minneapolis,
Minnesota
| $254M | +$17.1M | 9 | 0.15% | Increased |
|
| 38 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $250M | -$10.8M | 22 | 0.24% | Reduced |
|
| 39 |
Mawer Investment Management
Calgary,
Alberta, Canada
| $247M | +$31.8M | 1 | 3.17% | Increased |
|
| 40 |
Janus Henderson Investors US
Denver,
Colorado
| $244M | +$11.8M | 8 | 0.21% | Increased |
|
| 41 |
VAM
Visium Asset Management
New York
| $220M | -$22.1M | 8 | 3.31% | Reduced |
|
| 42 |
BlackRock Advisors
Wilmington,
Delaware
| $220M | -$127M | 28 | 0.23% | Reduced |
|
| 43 |
Lazard Asset Management
New York
| $216M | +$520K | 6 | 0.5% | Increased |
|
| 44 |
First Trust Advisors
Wheaton,
Illinois
| $201M | -$61.5M | 5 | 0.52% | Reduced |
|
| 45 |
Dimensional Fund Advisors
Austin,
Texas
| $199M | +$9.08M | 8 | 0.12% | Increased |
|
| 46 |
Parnassus Investments
San Francisco,
California
| $193M | -$45.3M | 1 | 1.29% | Reduced |
|
| 47 |
EARNEST Partners
Atlanta,
Georgia
| $186M | -$5.87M | 1 | 1.9% | Reduced |
|
| 48 |
UBS AM
Chicago,
Illinois
| $186M | -$19.7M | 13 | 0.21% | Reduced |
|
| 49 |
ClearBridge Investments
New York
| $180M | -$26.2M | 4 | 0.21% | Reduced |
|
| 50 |
Boston Partners
Boston,
Massachusetts
| $174M | +$14.9M | 1 | 0.25% | Increased |
|